Search the web
Welcome, Guest
[Sign Out, My Account]

Thursday, January 29 2015 7:27pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery
More On This Industry
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
Industry Market Summary
Drug Delivery
Composite Value: 1911.3
Today's Change: +0.47%
S&P 500: +0.95%
chart for
[Drug Delivery (^YHOh786)]
Drug Delivery News
Columbia Laboratories Announces Search For New Board Member, Impending Retirement of Chairman Stephen G. Kasnet; Amendment to Increase Permissible Ownership Levels Under Shareholder Rights Plan
Thu 6:50 am ET (PR Newswire)
BOSTON, Jan. 29, 2015 /PRNewswire/ -- Columbia Laboratories, Inc. (CBRX) ("Columbia" or "the Company"), a specialty pharmaceutical company focused on pharmaceuticals for women's health, today announced that the Company's Chairman, Stephen G. Kasnet, has informed the Company that he does not intend to stand for reelection to the Board of Directors when his current term expires at the next annual shareholder meeting, which is expected to be held in May, 2015. Frank Condella, CEO and President of Columbia, stated, "Steve has served Columbia as Chairman since 2004. Under his extraordinary leadership, the Company successfully created a significant revenue stream from proprietary formulations developed by the Company, recruited a skilled and experienced management team, strengthened the balance sheet, completed the acquisition of Molecular Profiles, and put new products into development.
Adamis Pharmaceuticals Receives Notice of Allowance for US and Japanese Patents for Its Dry Powder Inhaler - (GlobeNewswire)
Petmed Express D/B/A 1-800-PetMeds Announces Its Third Quarter Financial Results and Its $0.17 Per Share Quarterly Dividend - (GlobeNewswire)
More News on Drug Delivery: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
Bio-Path Holdings, Inc. [BPTH] +4.44% $200.8 M
Columbia Laboratories, Inc. [CBRX] +4.34% $57.1 M
Adamis Pharmaceuticals Corporat [ADMP] +2.04% $72.3 M
CLINIGEN GRP [CLIN.L] +1.18% -$1000.0 K
Alkermes plc [ALKS] +1.11% $10.4 B
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
WALGREEN [WGN.DE] -1.14% $54.9 B
Valeant Pharmaceuticals Interna [VRX] +0.57% $53.9 B
CLINIGEN GRP [CLIN.L] +1.18% $41.0 B
Alkermes plc [ALKS] +1.11% $10.4 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
03/25/15 BPHA3.SA Brasil Pharma SA Q4 2014 Earnings Release
03/26/15 RADL3.SA Raia Drogasil SA Q4 2014 Earnings Release
04/28/15 600998.SS Jointown Pharmaceutical Group Co Ltd Q4 2014 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
01/20/15 PETS PetMed Express, Inc. upside earnings surprise (+9.09%)
11/14/14 ADMP Adamis Pharmaceuticals Corporat downside earnings surprise (-53.85%)
11/12/14 BPHA3.SA BR PHARMA -ON NM downside earnings surprise (-2500.00%)
More Recent Events...
Sponsor Results
Biomarker Discovery!
Full service for biomarker discovery. Hundreds of targets analyzed!
United Science QuEChERS
A Better Way to Recover your Planar Pesticides. No Toluene. No kidding.
Local Debt Management
Go To To Find Financial Information & Services Near You!
(What's This?)
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:121B
Price / Earnings:NM
Price / Book:-6.3
Net Profit Margin (mrq):-16.6%
Price To Free Cash Flow (mrq):-24.6
Return on Equity:-15.4%
Total Debt / Equity:112.0
Dividend Yield:0.1%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
Unusually Active Boards
Board Variance

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?